HomePharma

Pharma

Pharma

Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug

Life Sciences Times - 0
Pharma

VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, CONSTANT, of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine Candidate

Life Sciences Times - 0
Pharma

COVID-19: Cytokine Storm and Coagulopathy Markers Controlled With Nichi Glucan Variants; The First of Its Kind Report in a Clinical Study

Life Sciences Times - 0
Pharma

NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments

Life Sciences Times - 0
Pharma

Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® With Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer

Life Sciences Times - 0
Pharma

Hunterian Medicine® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development

Life Sciences Times - 0
Pharma

RxCell Inc., A*STAR’s IMCB, NUS, and SERI Collaborate to Develop Cellular Therapeutics for Age-related Diseases

Life Sciences Times - 0
Pharma

BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® for Treatment of Patients with Waldenström’s Macroglobulinemia

Life Sciences Times - 0
Pharma

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

Life Sciences Times - 0
Pharma

ABIONYX Pharma Announces Positive Preclinical Results in a Model of Uveitis

Life Sciences Times - 0
Pharma

Animal Milk Oligosaccharides Can Protect Pet’s Microbiome During Antibiotic Treatment

Life Sciences Times - 0
Pharma

EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs

Life Sciences Times - 0
1...717273...91Page 72 of 91

Most Read